14.88
price up icon1.36%   0.20
after-market After Hours: 15.53 0.65 +4.37%
loading
Eton Pharmaceuticals Inc stock is traded at $14.88, with a volume of 243.01K. It is up +1.36% in the last 24 hours and up +0.20% over the past month. Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$14.68
Open:
$15.01
24h Volume:
243.01K
Relative Volume:
0.90
Market Cap:
$387.65M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-57.23
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
+0.68%
1M Performance:
+0.20%
6M Performance:
+152.20%
1Y Performance:
+320.34%
1-Day Range:
Value
$14.44
$15.20
1-Week Range:
Value
$12.73
$15.73
52-Week Range:
Value
$3.03
$18.41

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Name
Name
Eton Pharmaceuticals Inc
Name
Phone
(847) 787-7361
Name
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Name
Employee
30
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
ETON's Discussions on Twitter

Compare ETON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
ETON
Eton Pharmaceuticals Inc
14.88 387.65M 31.38M -6.69M -1.84M -0.26
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.75 73.33B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.13 47.80B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.37 46.89B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.29 18.67B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.53 13.99B 612.78M -86.37M -62.91M -0.87

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-23-25 Reiterated H.C. Wainwright Buy
Jan-10-25 Initiated B. Riley Securities Buy
Jan-06-25 Reiterated H.C. Wainwright Buy
Sep-04-24 Resumed H.C. Wainwright Buy
May-06-24 Initiated Craig Hallum Buy
Oct-14-21 Resumed B. Riley Securities Buy
Jan-04-21 Reiterated H.C. Wainwright Buy
Sep-20-19 Initiated B. Riley FBR Buy
Jun-10-19 Initiated H.C. Wainwright Buy
View All

Eton Pharmaceuticals Inc Stock (ETON) Latest News

pulisher
Mar 19, 2025

5 Analysts Assess Eton Pharmaceuticals: What You Need To Know - Benzinga

Mar 19, 2025
pulisher
Mar 19, 2025

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025
pulisher
Mar 19, 2025

B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating - Marketscreener.com

Mar 19, 2025
pulisher
Mar 19, 2025

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Canada Finance

Mar 19, 2025
pulisher
Mar 18, 2025

Eton Pharmaceuticals Reports Record Q4 Revenue Growth - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Eton Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Earnings Scheduled For March 18, 2025 - Benzinga

Mar 18, 2025
pulisher
Mar 17, 2025

Eton Pharmaceuticals (NASDAQ:ETON) shareholder returns have been incredible, earning 421% in 5 years - Simply Wall St

Mar 17, 2025
pulisher
Mar 16, 2025

(ETON) On The My Stocks Page - Stock Traders Daily

Mar 16, 2025
pulisher
Mar 15, 2025

Eton Pharmaceuticals nears NDA submission for new drug By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 14, 2025

Eton Pharma Plans FDA Filing For ET-600 Oral Desmopressin Next Month, Eyes 2026 Launch - Benzinga India

Mar 14, 2025
pulisher
Mar 14, 2025

Eton Pharma rises on study results for rare disease drug - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 14, 2025
pulisher
Mar 14, 2025

Eton's Diabetes Drug Candidate Passes Bioequivalence Study -March 14, 2025 at 07:21 am EDT - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Eton Pharmaceuticals nears NDA submission for new drug - Investing.com

Mar 14, 2025
pulisher
Mar 14, 2025

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600 - Eagle-Tribune

Mar 14, 2025
pulisher
Mar 14, 2025

Breakthrough for Pediatric Diabetes: Eton's Liquid Desmopressin Aces Pivotal Trial - StockTitan

Mar 14, 2025
pulisher
Mar 10, 2025

Rocket Companies, Novo Nordisk And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga India

Mar 10, 2025
pulisher
Mar 06, 2025

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

Eton Pharmaceuticals (ETON) to Release Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Trading (ETON) With Integrated Risk Controls - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

How Will Eton's Rare Disease Acquisitions Impact Future Growth? Investor Day Set to Reveal Strategy - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

Eton Pharmaceuticals Launches Galzin Capsules for Wilson Disease Treatment -March 03, 2025 at 11:48 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Eton Pharmaceuticals launches FDA-approved Wilson disease treatment - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Only FDA-Approved Zinc Treatment for Wilson Disease Now AvailableWhat Makes Galzin Different? - StockTitan

Mar 03, 2025
pulisher
Mar 01, 2025

60,432 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Anchor Capital Advisors LLC - MarketBeat

Mar 01, 2025
pulisher
Feb 23, 2025

(ETON) Trading Report - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 21, 2025

Acuitas Investments LLC Has $2.48 Million Stock Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Insider Buying: Opaleye Management Inc., Eton Pharmaceuticals Inc [ETON] 10% Owner invested 10,000 shares - Knox Daily

Feb 20, 2025
pulisher
Feb 17, 2025

What Are You Thinking About Investing In Eton Pharmaceuticals Inc (NASDAQ: ETON) Stock? - Stocks Register

Feb 17, 2025
pulisher
Feb 15, 2025

Here's Why Momentum in Eton Pharmaceuticals (ETON) Should Keep going - MSN

Feb 15, 2025
pulisher
Feb 12, 2025

Learn to Evaluate (ETON) using the Charts - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 12, 2025

Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World

Feb 12, 2025
pulisher
Feb 11, 2025

Eton Pharmaceuticals Stock Hits All-Time High of $17.57 - MSN

Feb 11, 2025
pulisher
Feb 08, 2025

FDA extends target action date for Eton's ET-400 - MSN

Feb 08, 2025
pulisher
Feb 08, 2025

Eton Pharmaceuticals Receives FDA Extension for NDA for ET-400On February 6, 2025, Eton Pharmaceuticals, Inc. announced through a press release that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUF - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Eton Pharmaceuticals receives new U.S. patent for ET-600 - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) 45% Jump Shows Its Popularity With Investors - Simply Wall St

Feb 07, 2025
pulisher
Feb 07, 2025

Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation -February 07, 2025 at 07:09 am EST - Marketscreener.com

Feb 07, 2025
pulisher
Feb 07, 2025

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600 - The Manila Times

Feb 07, 2025
pulisher
Feb 07, 2025

Major Patent Win: Eton's Game-Changing Liquid Diabetes Drug Gets 20-Year Protection - StockTitan

Feb 07, 2025
pulisher
Feb 06, 2025

Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May -February 06, 2025 at 10:15 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Eton Pharmaceuticals : FDA Extends ET-400 Review to Late May -February 06, 2025 at 08:37 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Eton Pharmaceuticals: FDA Extends ET-400 Review to Late May - MarketWatch

Feb 06, 2025
pulisher
Feb 06, 2025

Eton Pharmaceuticals: FDA extends PDUFA date for NDA for ET-400 to 5/28 - TipRanks

Feb 06, 2025
pulisher
Feb 06, 2025

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire

Feb 06, 2025

Eton Pharmaceuticals Inc Stock (ETON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.83
price up icon 0.19%
$34.34
price down icon 0.09%
$103.28
price up icon 1.04%
$110.31
price up icon 0.56%
$9.42
price down icon 1.05%
$131.53
price up icon 0.06%
Cap:     |  Volume (24h):